Mapping the Secret Complexity of Tumors To Defeat Aggressive Cancers
What makes cancer so difficult to defeat? Why do so many patients respond well to a particular treatment, only to relapse months or years later? The answer lies within the complex cellular makeup of cancerous tumors.
The Importance of Science Communication With Dr Carl May
Watch this Teach Me in 10 with Dr Carl May to discover the importance of science communication and to learn Mays's hints, tips and tricks.
The Surprising Secrets of Hummingbird Flight
In just a matter of seconds, hummingbirds can perform astonishing aerial acrobatics, eat lunch in midair, pollinate a flower, even escape threats while upside-down. And they can do this all while achieving sustained hovering flight, an aerial feat no other bird can perform. How do they do it? Kristiina J. Hurme and Alejandro Rico-Guevara explore the incredible flying capabilities of hummingbirds.
What Is Cancer and How Does It Start?
In this video, Cancer Research UK explains what cancer is and how it starts.
TSE Explores Cancer Research – The Future of Cancer Research
In this episode we will be speaking with Professor Bissan Al-Lazikani, from the Institute of Cancer Research about how data science and machine learning approaches are used for cancer drug discovery and treatment adaptation.
How To Choose Your Tools for 3D Cell Culture
Join this Teach Me in 10 session to hear Corning Life Sciences application scientists walk you through common research goals and the most suitable 3D cell culture solutions for each.
TSE Explores Cancer Research – Biomarkers in Cancer Research
In this episode we will be speaking with Professor Tony Whetton, the Director of the Stoller Biomarker Discovery Centre about biomarkers for cancer research and their importance.
Harnessing the Immune System Against Cancer by Targeting CD25
The shared CD25 activation mechanism on regulatory and effector T cells has been a big challenge when designing immunotherapy drugs. Now, researchers have developed a new antibody that can target CD25 specifically on regulatory T cells while leaving effector T cells intact.
TSE Explores Cancer Research – CRISPR in Cancer Research
In this episode we will be speaking with Hashem Al-Ghaili, Molecular Biotechnologist and Science Communicator about the use of CRISPR in cancer.
Targeting a Rare Brain Cancer With Spherical Nucleic Acids
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists.